Literature DB >> 19387767

Physicians make different decisions from nephrologists at serum creatinine 2.0 mg/dl.

Kaichiro Tamba1, Eiji Kusano2, Kaoru Tabei3, Eiji Kajii4, Yasushi Asano2.   

Abstract

BACKGROUND: It is very important, but not clear, how physicians differ from nephrologists in treatment of renal insufficiency. AIM: To demonstrate differences in decision-making in treatment of renal insufficiency between physicians and nephrologists. DESIGN OF STUDY: Postal questionnaire.
SETTING: All physicians were graduates from one medical school and certified by the Japanese Society of Internal Medicine. Nephrologists were certified by the Society and the Japanese Society of Nephrology.
METHOD: Questionnaires were sent to 1,395 physicians and 385 nephrologists, including audit of serum creatinine concentration that would indicate referral to nephrologist, audit of continuation of angiotensin converting enzyme inhibitor (ACEI) for a case of renal insufficiency and mild hyperkalemia due to ACEI. Outputs were proportion that selected "serum creatinine 177 micromol/l (2.0 mg/dl) and over" as a referral point to the nephrologist, and proportion that chose "suspend ACEI" for a case of renal insufficiency and mild hyperkalemia due to ACEI.
RESULTS: Six hundred and fourteen physicians replied (44%), and 111 certified in internal medicine were extracted from them. One hundred and eighty-six certified nephrologists replied (47%), and 114 certified in internal medicine were extracted. The proportion that chose "177 micromol/l" as a referral point to the nephrologist was 20% for physicians and 61% for nephrologists (P < 0.0001). An additional 17% of nephrologists recommended creatinine concentration below 177 micromol/l, whereas no such opinion was found among physicians. The proportion that chose "suspend ACEI" was 45% for physicians and 16% for nephrologists (P < 0.0001).
CONCLUSION: There is significant difference between decisions made by physicians and nephrologists regarding treatment for patients with serum creatinine concentration of 177 micromol/l.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387767     DOI: 10.1007/s10157-009-0176-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  14 in total

1.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

Authors:  D Fliser; E Ritz
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

4.  Identifying patients with chronic kidney disease from general practice computer records.

Authors:  Simon de Lusignan; Tom Chan; Paul Stevens; Donal O'Donoghue; Nigel Hague; Billy Dzregah; Jeremy Van Vlymen; Mel Walker; Sean Hilton
Journal:  Fam Pract       Date:  2005-04-06       Impact factor: 2.267

5.  Cystatin C measurement and its practical use in patients with various renal diseases.

Authors:  S Tian; E Kusano; T Ohara; K Tabei; Y Itoh; T Kawai; Y Asano
Journal:  Clin Nephrol       Date:  1997-08       Impact factor: 0.975

Review 6.  Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure.

Authors:  G T Obrador; B J Pereira
Journal:  Am J Kidney Dis       Date:  1998-03       Impact factor: 8.860

7.  Early referral and its impact on emergent first dialyses, health care costs, and outcome.

Authors:  R J Schmidt; J R Domico; M I Sorkin; G Hobbs
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

8.  Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

Authors:  R T Gansevoort; W J Sluiter; M H Hemmelder; D de Zeeuw; P E de Jong
Journal:  Nephrol Dial Transplant       Date:  1995-11       Impact factor: 5.992

9.  Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population.

Authors:  Kiyoshi Ichihara; Kensuke Saito; Yoshihisa Itoh
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

10.  Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.

Authors:  P A Kalra; M Kumwenda; P MacDowall; M O Roland
Journal:  BMJ       Date:  1999-01-23
View more
  1 in total

1.  Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR study.

Authors:  Konstantinos Sombolos; Demitrios Tsakiris; John Boletis; Demetrios Vlahakos; Kostas C Siamopoulos; Vassilios Vargemezis; Pavlos Nikolaidis; Christos Iatrou; Eugene Dafnis; Konstantinos Xynos; Christos Argyropoulos
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.